William Thomas

Dr. William Thomas


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2020 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Open access
PDF file
DWD. White
D. White
SMS. MacDonald
S. MacDonald
TBT. Bull
T. Bull
MHM. Hayman
M. Hayman
RMR. de Monteverde-Robb
R. de Monteverde-Robb
WTWilliam Thomas
William Thomas
Patients with COVID-19 have a coagulopathy and high thrombotic risk. In a cohort of 69 intensive care unit (ICU) patients we investigated for evidence of heparin resistance in those that have received therapeutic anticoagulation. 15 of the patients have received therapeutic anticoagulation with either unfractionated heparin (UFH) or low molecular weight heparin (LMWH), of which full information was available on 14 patients. Heparin resistance to UFH was documented in 8/10 (80%) patients and sub-optimal peak anti-Xa following therapeutic LMWH in 5/5 (100%) patients where this was measured (some patients received both anticoagulants sequentially). Spiking plasma from 12 COVID-19 ICU patient samples demonstrated decreased in-vitro recovery of anti-Xa compared to normal pooled plasma. In conclusion, we have found evidence of heparin resistance in critically unwell COVID-19 patients. Further studies investigating this are required to determine the optimal thromboprophylaxis in COVID-19 and management of thrombotic episodes.

1 July 2020 in Thrombosis Research
Verified
Journal Article
Closed access
WTWilliam Thomas
William Thomas
JVJ. Varley
J. Varley
AJA. Johnston
A. Johnston
ESE. Symington
E. Symington
MRM. Robinson
M. Robinson
MBM. Besser
M. Besser

5 September 2020 in International Journal of Laboratory Hematology
Verified
Journal Article
Open access
PDF file
DWDanielle White
Danielle White
SMStephen MacDonald
Stephen MacDonald
TETara Edwards
Tara Edwards
CBChris Bridgeman
Chris Bridgeman
MHMegan Hayman
Megan Hayman
WTWilliam Thomas
William Thomas
Introduction: Patients with COVID‐19 are known to have a coagulopathy with a thrombosis risk. It is unknown whether this is due to a generalized humoral prothrombotic state or endothelial factors such as inflammation and dysfunction. The aim was to further characterize thrombin generation using a novel analyser (ST Genesia, Diagnostica Stago, Asnières, France) and a panel of haematological analytes in patients with COVID‐19.Methods: Platelet poor plasma of 34 patients with noncritical COVID‐19 was compared with 75 patients with critical COVID‐19 (as defined by WHO criteria) in a retrospective study by calibrated automated thrombography and ELISA. Patients were matched for baseline characteristics of age and gender.Results: Critical patients had significantly increased fibrinogen, CRP, interleukin‐6 and D‐dimer compared to noncritical patients. Thrombin generation, in critical patients, was right shifted without significant differences in peak, velocity index or endogenous thrombin potential. Tissue plasminogen activator (tPA), tissue factor pathway inhibitor (TFPI) and vascular endothelial growth factor (VEGF) were significantly increased in the critical versus noncritical patients. Critically ill patients were on haemodiafiltration (31%; heparin used in the circuit) or often received escalated prophylactic low‐molecular weight heparin.Conclusion: These results confirm increased fibrinogen and D‐dimer in critical COVID‐19‐infected patients. Importantly, disease severity did not increase thrombin generation (including thrombin‐antithrombin complexes and prothrombin fragment 1 + 2) when comparing both cohorts; counter‐intuitively critical patients were hypocoaguable. tPA, TFPI and VEGF were increased in critical patients, which are hypothesized to reflect endothelial dysfunction and/or contribution of heparin (which may cause endothelial TFPI/tPA release).

23 October 2020 in Haemophilia
Verified
Journal Article
Closed access
PDF file
WTWilliam Thomas
William Thomas
KDKate Downes
Kate Downes
MDMichael J. R. Desborough
Michael J. R. Desborough

30 June 2021 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
GMGary Moore
Gary Moore
PJPaul O. Jones
Paul O. Jones
SPSean Platton
Sean Platton
NHNadia Hussain
Nadia Hussain
DWDanielle White
Danielle White
KDKatrien MJ Devreese
Katrien MJ Devreese

17 April 2022 in British Journal of Haematology
Verified
Journal Article
Closed access
ADAndrew J. Doyle
Andrew J. Doyle
MSMatthew J. Stubbs
Matthew J. Stubbs
WLWill Lester
Will Lester
WTWilliam Thomas
William Thomas
JWJohn‐Paul Westwood
John‐Paul Westwood
MSMarie Scully
Marie Scully